Streptozocin chemotherapy for advanced/metastatic well-differentiated neuroendocrine tumors: an analysis of a multi-center survey in Japan

被引：0
作者：
Taku Aoki
Norihiro Kokudo
Izumi Komoto
Kyoichi Takaori
Wataru Kimura
Keiji Sano
Takeshi Takamoto
Takuya Hashimoto
Takuji Okusaka
Chigusa Morizane
Tetsuhide Ito
Masayuki Imamura
机构：
[1] The University of Tokyo,Hepato
[2] The University of Tokyo,Biliary
[3] Kansai Electric Power Company Hospital,Pancreatic Surgery Division, Department of Surgery, Graduate School of Medicine
[4] Kyoto University,Artificial Organ and Transplantation Division, Department of Surgery, Graduate School of Medicine
[5] Yamagata University Faculty of Medicine,Department of Surgery
[6] Teikyo University School of Medicine,Department of Hepatobiliary
[7] Japanese Red Cross Medical Center,Pancreatic Surgery and Transplantation, Graduate School of Medicine
[8] National Cancer Center Hospital,Department of Gastroenterological, Breast, Thyroid, and General Surgery
[9] Kyushu University,Department of Surgery
来源：
Journal of Gastroenterology | 2015年 / 50卷
关键词：
Neuroendocrine tumors; Streptozocin; Multi-center survey; Tumor response; Progression-free survival rate;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：769 / 775
页数：6
相关论文
共 36 条
  • [21] Systemic Therapy of Advanced Well-differentiated Small Bowel Neuroendocrine Tumors Progressive on Somatostatin Analogues
    Parul Agarwal
    Amr Mohamed
    Current Treatment Options in Oncology, 2022, 23 : 1233 - 1246
  • [22] Systemic Therapy of Advanced Well-differentiated Small Bowel Neuroendocrine Tumors Progressive on Somatostatin Analogues
    Agarwal, Parul
    Mohamed, Amr
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2022, 23 (09) : 1233 - 1246
  • [23] Capecitabine and temozolomide (CAPTEM) for metastatic, well-differentiated neuroendocrine cancers: The Pancreas Center at Columbia University experience
    Fine, Robert L.
    Gulati, Anthony P.
    Krantz, Benjamin A.
    Moss, Rebecca A.
    Schreibman, Stephen
    Tsushima, Dawn A.
    Mowatt, Kelley B.
    Dinnen, Richard D.
    Mao, Yuehua
    Stevens, Peter D.
    Schrope, Beth
    Allendorf, John
    Lee, James A.
    Sherman, William H.
    Chabot, John A.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2013, 71 (03) : 663 - 670
  • [24] Peptide Receptor Radionuclide Therapy Outcomes in a North American Cohort With Metastatic Well-Differentiated Neuroendocrine Tumors
    Sharma, Nancy
    Naraev, Boris G.
    Engelman, Eric G.
    Zimmerman, M. Bridget
    Bushnell, David L., Jr.
    O'Dorisio, Thomas M.
    O'Dorisio, M. Sue
    Menda, Yusuf
    Mueller-Brand, Jan
    Howe, James R.
    Halfdanarson, Thorvardur R.
    PANCREAS, 2017, 46 (02) : 151 - 156
  • [25] Everolimus in advanced, progressive, well-differentiated, non-functional neuroendocrine tumors: RADIANT-4 lung subgroup analysis
    Fazio, Nicola
    Buzzoni, Roberto
    Delle Fave, Gianfranco
    Tesselaar, Margot E.
    Wolin, Edward
    Van Cutsem, Eric
    Tomassetti, Paola
    Strosberg, Jonathan
    Voi, Maurizio
    Bubuteishvili-Pacaud, Lida
    Ridolfi, Antonia
    Herbst, Fabian
    Tomasek, Jiri
    Singh, Simron
    Pavel, Marianne
    Kulke, Matthew H.
    Valle, Juan W.
    Yao, James C.
    CANCER SCIENCE, 2018, 109 (01): : 174 - 181
  • [26] Appendiceal Well-Differentiated Neuroendocrine Tumors: A Single-Center Experience and New Insights into the Effective Use of Immunohistochemistry
    Shibahara, Yukiko
    Krzyzanowska, Monika
    Vajpeyi, Rajkumar
    INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY, 2023, 31 (03) : 252 - 259
  • [27] The NETPET Score: Combining FDG and Somatostatin Receptor Imaging for Optimal Management of Patients with Metastatic Well-Differentiated Neuroendocrine Tumors
    Hindie, Elif
    THERANOSTICS, 2017, 7 (05): : 1159 - 1163
  • [28] Differences between Well-Differentiated Neuroendocrine Tumors and Ductal Adenocarcinomas of the Pancreas Assessed by Multi-Omics Profiling
    Starzynska, Teresa
    Karczmarski, Jakub
    Paziewska, Agnieszka
    Kulecka, Maria
    Kusnierz, Katarzyna
    Zeber-Lubecka, Natalia
    Ambrozkiewicz, Filip
    Mikula, Michal
    Kos-Kudla, Beata
    Ostrowski, Jerzy
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (12) : 1 - 18
  • [29] Efficacy and safety of sunitinib in Japanese patients with progressive, advanced/metastatic, well-differentiated, unresectable pancreatic neuroendocrine tumors: final analyses from a Phase II study
    Ito, Tetsuhide
    Tori, Masayuki
    Hashigaki, Satoshi
    Kimura, Nobuyuki
    Sato, Kazuo
    Ohki, Emiko
    Sawaki, Akira
    Okusaka, Takuji
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2019, 49 (04) : 354 - 360
  • [30] Surgery Versus Surveillance for Well-Differentiated, Nonfunctional Pancreatic Neuroendocrine Tumors: An 11-Year Analysis of the National Cancer Database
    Assi, Hussein A.
    Mukherjee, Sarbajit
    Kunz, Pamela L.
    Machiorlatti, Michael
    Vesely, Sara
    Pareek, Vipul
    Hatoum, Hassan
    ONCOLOGIST, 2020, 25 (02) : E276 - E283
1234